SCHEMBL4361680

SCHEMBL4361680

CN(C)C1(C(NC(=O)c2cc(C(F)(F)F)nc3ccccc23)c2ccccc2)CCCCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR3 P29371 17/20 0.45
ADORA2A P29274 1/20 0.42
ADORA1 P30542 1/20 0.42
SLC2A1 P11166 1/20 0.41
TACR2 P21452 5/20 0.40
TSHR P16473 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2C9 P11712 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
NFKB1 P19838 1/20 0.40
MTOR P42345 1/20 0.40
BLM P54132 1/20 0.40
PMP22 Q01453 1/20 0.40
KMT2A Q03164 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HSD17B10 Q99714 1/20 0.40
CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4357027 0.99 TACR3 (0.46) TACR3ADORA2AADORA1SLC2A1TACR2
SCHEMBL4351001 0.90 TACR3 (0.38) TACR3SLC2A1MEN1KMT2ANPSR1
SCHEMBL8263391 0.90 GAA (0.49) TACR3ADORA2AADORA1SLC2A1KDM4E
SCHEMBL4358870 0.90 TACR3 (0.43) TACR3ADORA2AADORA1SLC2A1TACR2
SCHEMBL4363718 0.89 TACR3 (0.43) TACR3ADORA2AADORA1SLC2A1TACR2
SCHEMBL4359090 0.89 KMT2A (0.40) TACR3ADORA2AADORA1SLC2A1MEN1
SCHEMBL4354537 0.87 MEN1 (0.37) TACR3MEN1KMT2A
SCHEMBL4352784 0.87 TACR3 (0.42) TACR3ADORA2AADORA1SLC2A1TACR2
SCHEMBL4355380 0.87 SLC6A9 (0.38) TACR3SLC2A1KMT2A
SCHEMBL3037099 0.86 TACR3 (0.45) TACR3SLC2A1KDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090286828-A1 2-AMINO-1-PHENYLETHYLCARBOXAMIDE DERIVATIVES GLAXO GROUP LIMITED (GB) 2009-11-19 US disclosed
US-20090286828-A1 2-AMINO-1-PHENYLETHYLCARBOXAMIDE DERIVATIVES GLAXO GROUP LIMITED (GB) 2009-11-19 US disclosed
US-20090286828-A1 2-AMINO-1-PHENYLETHYLCARBOXAMIDE DERIVATIVES GLAXO GROUP LIMITED (GB) 2009-11-19 US disclosed
WO-2006067430-A1 2-AMINO-1-PHENYLETHYLCARBOXAMIDE DERIVATIVES GLAXO GROUP LIMITED (GB) 2006-06-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286828-A1 2-AMINO-1-PHENYLETHYLCARBOXAMIDE DERIVATIVES PNMT, SLC18A2, COMT TACR3 2005/4885ADORA2A 717/4885ADORA1 186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.